Study Description
To compare the efficacy and safety of remibrutinib versus teriflunomide in patients with relapsing multiple sclerosis
The study CLOU064C12302 consists of an initial Core Part (CP) (maximum duration per participant of up to 30 months), followed by an Extension Part (EP, of up to 5 years duration) for eligible participants.
The Core Part is a randomized, double-blind, double-dummy, active comparator-controlled, fixed-dose, parallel-group, multi-center study in approximately 800 participants with relapsing multiple sclerosis (RMS).
The Extension Part is an open-label, single-arm, fixed-dose design in which eligible participants are treated with remibrutinib for up to 5 years.
A second study of identical design (CLOU064C12301) will be conducted simultaneously. Both studies will be conducted globally and data from the two studies will be pooled for some of the endpoints.
Interventions
Remibrutinib
Teriflunomide
Eligibility Criteria
Inclusion Criteria:
18 to 55 years of age
Diagnosis of RMS according to the 2017 McDonald diagnostic criteria
At least: 1 documented relapse within the previous year. OR 2 documented relapses within the previous 2 years, OR 1 active Gadolinium (Gd)-enhancing lesion in the 12 months.
EDSS score of 0 to 5.5 (inclusive)
Neurologically stable within 1 month
Exclusion Criteria:
Diagnosis of primary progressive multiple sclerosis (PPMS)
Disease duration of more than 10 years in participants with EDSS score of 2 or less at screening
History of clinically significant CNS disease other than MS
Ongoing substance abuse (drug or alcohol)
History of malignancy of any organ system (other than complete resection of localized basal cell carcinoma of the skin or in situ cervical cancer),
Participants with history of confirmed Progressive Multifocal Leukoencephalopathy (PML) or Neurological symptoms consistent with PML
suicidal ideation or behavior
Evidence of clinically significant cardiovascular, neurological, psychiatric, pulmonary , renal, hepatic, endocrine, metabolic, hematological disorders or gastrointestinal disease that can interfere with interpretation of the study results or protocol adherence
Participants who have had a splenectomy
Active clinically significant systemic bacterial, viral, parasitic or fungal infections
Positive results for syphilis or tuberculosis testing
Uncontrolled disease states, such as asthma, or inflammatory bowel disease, where flares are commonly treated with oral or parenteral corticosteroids
Active, chronic disease of the immune system (including stable disease treated with immune therapy (e.g. Leflunomide, Methotrexate)) other than MS (e.g. rheumatoid arthritis, systemic lupus erythematosus, etc.) with the exception of well-controlled diabetes or thyroid disorder.
Participants with a known immunodeficiency syndrome (AIDS, hereditary immune deficiency, drug induced immune deficiency), or tested positive for HIV antibody
History or current treatment for hepatic disease including but not limited to acute or chronic hepatitis, cirrhosis or hepatic failure or participants with moderate or severe hepatic impairment (Child-Pugh class C) or any chronic liver or biliary disease.
History of severe renal disease or creatinine level
Participants at risk of developing or having reactivation of hepatitis
Hematology parameters at screening:
Hemoglobin: < 10 g/dl (<100g/L)
Platelets: < 100000/mm3 (<100 x 109/L)
Absolute lymphocyte count < 800/mm3 (<0.8 x 109/L)
White blood cells: <3 000/mm3 (<3.0 x 109/L)
Neutrophils: < 1 500/mm3 (<1.5 x 109/L)
B-cell count < 50% lower limit of normal (LLN) or total IgG & total IgM < LLN (only required for participants who had a history of receiving B-cell therapies, such as rituximab, ocrelizumab or ofatumumab, prior to screening)
History or current diagnosis of significant ECG abnormalities
Resting QTcF ≥450 msec (male) or ≥460 msec (female) at pre-treatment (prior to randomization)
Use of other investigational drugs
Requirement for anticoagulant medication or use of dual anti-platelet therapy Significant bleeding risk or coagulation disorders,
History of gastrointestinal bleeding
Major surgery within 8 weeks prior to screening
History of hypersensitivity to any of the study drugs or excipients
Pregnant or nursing (lactating) female participants, prior to randomization
Women of childbearing potential not using highly effective contraception
Sexually active males not agreeing to use condom
Have received any live or live-attenuated vaccines within 6 weeks of randomization or requirement to receive these vaccinations during study
Use of strong CYP3A4 inhibitors or use of moderate or strong CYP3A4 inducers within two weeks prior to randomization
Inclusion to Extension part:
• patient who complete the Core Part of the study on double-blind study treatment and conduct the Accelerated Elimination Procedure (AEP)
Other inclusion and exclusion criteria may apply
Study Location
Novartis Investigative Site
Recruiting
Rosario,Santa Fe,S2000BZL,Argentina
Novartis Investigative Site
Recruiting
San Miguel De,Tucuman,T4000,Argentina
Novartis Investigative Site
Recruiting
Bombal,Mendoza,M5500DXO,Argentina
Novartis Investigative Site
Recruiting
Buenos Aires,C1012AAR,Argentina
Novartis Investigative Site
Recruiting
Vitoria,ES,29055-450,Brazil
Novartis Investigative Site
Recruiting
Porto Alegre,RS,90110-000,Brazil
Novartis Investigative Site
Recruiting
Porto Alegre,RS,90430-001,Brazil
Novartis Investigative Site
Recruiting
Joinville,Santa Catarina,89202-165,Brazil
Novartis Investigative Site
Recruiting
Sao Paulo,01240-020,Brazil
Novartis Investigative Site
Recruiting
Brasilia,DF,70200-730,Brazil
Novartis Investigative Site
Recruiting
Curitiba,PR,81210-310,Brazil
Novartis Investigative Site
Recruiting
Porto Alegre,Rio Grande Do Sul,90035-001,Brazil
Novartis Investigative Site
Recruiting
Sofia,1407,Bulgaria
Novartis Investigative Site
Recruiting
Sofia,1413,Bulgaria
Novartis Investigative Site
Recruiting
Plovdiv,4002,Bulgaria
Novartis Investigative Site
Recruiting
Sofia,1309,Bulgaria
Novartis Investigative Site
Recruiting
Halifax,Nova Scotia,B3H 4K4,Canada
Novartis Investigative Site
Recruiting
Edmonton,Alberta,T6G 2B7,Canada
Novartis Investigative Site
Recruiting
Greenfield Park,Quebec,J4V 2J2,Canada
Novartis Investigative Site
Recruiting
Ottawa,Ontario,K1H 8L6,Canada
Novartis Investigative Site
Recruiting
Levis,Quebec,G6W 0M5,Canada
Novartis Investigative Site
Recruiting
Yinchuan,Ningxia,100039,China
Novartis Investigative Site
Recruiting
Shanghai,200025,China
Novartis Investigative Site
Recruiting
Shanghai,200040,China
Novartis Investigative Site
Recruiting
Wenzhou,Zhejiang,325000,China
Novartis Investigative Site
Recruiting
Taiyuan,Shanxi,030001,China
Novartis Investigative Site
Recruiting
Hangzhou,Zhejiang,310006,China
Novartis Investigative Site
Recruiting
Fuzhou,Fujian,350025,China
Novartis Investigative Site
Recruiting
Hangzhou,Zhejiang,310016,China
Novartis Investigative Site
Recruiting
Wuhan,Hubei,430030,China
Novartis Investigative Site
Recruiting
Nanjing,Jiangsu,210029,China
Novartis Investigative Site
Recruiting
Wuhan,Hubei,430060,China
Novartis Investigative Site
Recruiting
Vukovar,32000,Croatia
Novartis Investigative Site
Recruiting
Split,HRV,21000,Croatia
Novartis Investigative Site
Recruiting
Zagreb,10000,Croatia
Novartis Investigative Site
Recruiting
Varazdin,HRV,42000,Croatia
Novartis Investigative Site
Recruiting
Tallinn,11315,Estonia
Novartis Investigative Site
Recruiting
Tartu,51014,Estonia
Novartis Investigative Site
Recruiting
Nantes,Cedex 1,44093,France
Novartis Investigative Site
Recruiting
Suresnes,92150,France
Novartis Investigative Site
Recruiting
Lille Cedex,59037,France
Novartis Investigative Site
Recruiting
Dijon,21034,France
Novartis Investigative Site
Recruiting
Lille,59000,France
Novartis Investigative Site
Recruiting
CAEN Cedex,14033,France
Novartis Investigative Site
Recruiting
Toulon Cedex 9,Val De Marne,83800,France
Novartis Investigative Site
Recruiting
Contamine Sur Arve,74130,France
Novartis Investigative Site
Recruiting
Toulouse Cedex 9,31059,France
Novartis Investigative Site
Recruiting
Clermont-Ferrand Cedex 1,63003,France
Novartis Investigative Site
Recruiting
Grenoble,38042,France
Novartis Investigative Site
Recruiting
Nimes,30029,France
Novartis Investigative Site
Recruiting
Nice Cedex,06202,France
Novartis Investigative Site
Recruiting
Gonesse,95500,France
Novartis Investigative Site
Recruiting
Amyntaio,53246,Greece
Novartis Investigative Site
Recruiting
Athens,Attica,11526,Greece
Novartis Investigative Site
Recruiting
Athens,115 28,Greece
Novartis Investigative Site
Recruiting
Larissa,GR,411 10,Greece
Novartis Investigative Site
Recruiting
Ioannina,GR,455 00,Greece
Novartis Investigative Site
Recruiting
Athens,12462,Greece
Novartis Investigative Site
Recruiting
Thessaloniki,GR 54636,Greece
Novartis Investigative Site
Recruiting
Amritsar,Punjab,143006,India
Novartis Investigative Site
Recruiting
Hyderabad,Telangana,500082,India
Novartis Investigative Site
Recruiting
New Delhi,Delhi,110 060,India
Novartis Investigative Site
Recruiting
Lucknow,Uttar Pradesh,226007,India
Novartis Investigative Site
Recruiting
Pune,Maharashtra,411013,India
Novartis Investigative Site
Recruiting
Kolkata,West Bengal,700017,India
Novartis Investigative Site
Recruiting
Orbassano,TO,10043,Italy
Novartis Investigative Site
Recruiting
Napoli,80131,Italy
Novartis Investigative Site
Recruiting
Modena,MO,41126,Italy
Novartis Investigative Site
Recruiting
Pozzilli,IS,86077,Italy
Novartis Investigative Site
Recruiting
Firenze,FI,50134,Italy
Novartis Investigative Site
Recruiting
Foggia,FG,71100,Italy
Novartis Investigative Site
Recruiting
Pavia,PV,27100,Italy
Novartis Investigative Site
Recruiting
Brindisi,BR,72100,Italy
Novartis Investigative Site
Recruiting
Messina,ME,98121,Italy
Novartis Investigative Site
Recruiting
Koriyama city,Fukushima,963-8052,Japan
Novartis Investigative Site
Recruiting
Fukuoka city,Fukuoka,812-8582,Japan
Novartis Investigative Site
Recruiting
Fukuoka,810-0022,Japan
Novartis Investigative Site
Recruiting
Kyoto-city,Kyoto,616-8255,Japan
Novartis Investigative Site
Recruiting
Kobe-shi,Hyogo,650-0017,Japan
Novartis Investigative Site
Recruiting
Moriguchi,Osaka,570-8507,Japan
Novartis Investigative Site
Recruiting
Sapporo city,Hokkaido,063-0005,Japan
Novartis Investigative Site
Recruiting
Shinjuku-ku,Tokyo,160 8582,Japan
Novartis Investigative Site
Recruiting
Kashihara city,Nara,634 8522,Japan
Novartis Investigative Site
Recruiting
Nagoya,Aichi,466 8560,Japan
Novartis Investigative Site
Recruiting
Isehara,Kanagawa,259-1193,Japan
Novartis Investigative Site
Recruiting
Shinjuku-ku,Tokyo,160-0023,Japan
Novartis Investigative Site
Recruiting
Kodaira,Tokyo,187-8551,Japan
Novartis Investigative Site
Recruiting
Sendai city,Miyagi,983 8512,Japan
Novartis Investigative Site
Recruiting
Nishinomiya,Hyogo,663 8501,Japan
Novartis Investigative Site
Recruiting
Suita,Osaka,565 0871,Japan
Novartis Investigative Site
Recruiting
Chiba,260 8677,Japan
Novartis Investigative Site
Recruiting
Niigata,951 8520,Japan
Novartis Investigative Site
Recruiting
Chihuahua,31203,Mexico
Novartis Investigative Site
Recruiting
Ciudad de Mexico,Distrito Federal,06700,Mexico
Novartis Investigative Site
Recruiting
Ciudad De Mexico,14050,Mexico
Novartis Investigative Site
Recruiting
Queretaro,76070,Mexico
Novartis Investigative Site
Recruiting
Katowice,40-123,Poland
Novartis Investigative Site
Recruiting
Krakow,31-637,Poland
Novartis Investigative Site
Recruiting
Zabrze,41-800,Poland
Novartis Investigative Site
Recruiting
Plewiska,Poznan,62-064,Poland
Novartis Investigative Site
Recruiting
Bialystok,15-704,Poland
Novartis Investigative Site
Recruiting
Wroclaw,51-685,Poland
Novartis Investigative Site
Recruiting
Katowice,40 571,Poland
Novartis Investigative Site
Recruiting
Santa Maria da Feira,4520 211,Portugal
Novartis Investigative Site
Recruiting
Braga,4710243,Portugal
Novartis Investigative Site
Recruiting
Lisboa,1600190,Portugal
Novartis Investigative Site
Recruiting
Matosinhos,Porto,4454509,Portugal
Novartis Investigative Site
Recruiting
Leiria,2410-104,Portugal
Novartis Investigative Site
Recruiting
Guaynabo,00968,Puerto Rico
Novartis Investigative Site
Recruiting
Constanta,900591,Romania
Novartis Investigative Site
Recruiting
Constanta,ROM,900123,Romania
Novartis Investigative Site
Recruiting
Campulung Muscel,ROM,115100,Romania
Novartis Investigative Site
Recruiting
Targu Mures,540136,Romania
Novartis Investigative Site
Recruiting
Banska Bystrica,975 17,Slovakia
Novartis Investigative Site
Recruiting
Bratislava,83305,Slovakia
Novartis Investigative Site
Recruiting
Banska Bystrica,974 04,Slovakia
Novartis Investigative Site
Recruiting
Maribor,2000,Slovenia
Novartis Investigative Site
Recruiting
Ljubljana,1000,Slovenia
Novartis Investigative Site
Recruiting
Celje,3000,Slovenia
Novartis Investigative Site
Recruiting
Rosebank,2196,South Africa
Novartis Investigative Site
Recruiting
Bloemfontein,Free State,9301,South Africa
Novartis Investigative Site
Recruiting
Pretoria,0041,South Africa
Novartis Investigative Site
Recruiting
Sevilla,Andalucia,41009,Spain
Novartis Investigative Site
Recruiting
Torrejon de Ardoz,Madrid,28850,Spain
Novartis Investigative Site
Recruiting
Madrid,28040,Spain
Novartis Investigative Site
Recruiting
Santiago de Compostela,Galicia,15706,Spain
Novartis Investigative Site
Recruiting
Barcelona,Catalunya,08003,Spain
Novartis Investigative Site
Recruiting
Valencia,Comunidad Valenciana,46017,Spain
Novartis Investigative Site
Recruiting
Pozuelo de Alarcon,Madrid,28223,Spain
Novartis Investigative Site
Recruiting
Valencia,46026,Spain
Novartis Investigative Site
Recruiting
Gijon,Asturias,33394,Spain
Novartis Investigative Site
Recruiting
Vitoria-Gasteiz,País Vasco,01009,Spain
Novartis Investigative Site
Recruiting
Madrid,28009,Spain
Novartis Investigative Site
Recruiting
Hospitalet de Llobregat,Barcelona,08907,Spain
Novartis Investigative Site
Recruiting
Stockholm,102 35,Sweden
Novartis Investigative Site
Recruiting
Stockholm,141 86,Sweden
Novartis Investigative Site
Recruiting
Izmir,35620,Turkey
Novartis Investigative Site
Recruiting
Pendik Istanbul,34899,Turkey
Novartis Investigative Site
Recruiting
Bursa,16140,Turkey
Novartis Investigative Site
Recruiting
Kayseri,38280,Turkey
Novartis Investigative Site
Recruiting
Samsun,55139,Turkey
Novartis Investigative Site
Recruiting
Kocaeli,41380,Turkey
Novartis Investigative Site
Recruiting
Sancaktepe,Istanbul,34785,Turkey
Novartis Investigative Site
Recruiting
Istanbul,34093,Turkey
Novartis Investigative Site
Recruiting
London,W1G 9JF,United Kingdom
Novartis Investigative Site
Recruiting
Frisco,Texas,75035,United States
Novartis Investigative Site
Recruiting
Boston,Massachusetts,02111,United States
Novartis Investigative Site
Recruiting
Miami,Florida,33136,United States
Novartis Investigative Site
Recruiting
Green Bay,Wisconsin,54311,United States
Novartis Investigative Site
Recruiting
Houston,Texas,77094,United States
Novartis Investigative Site
Recruiting
Naples,Florida,34102,United States
Novartis Investigative Site
Recruiting
Orlando,Florida,32803,United States
Novartis Investigative Site
Recruiting
Bradenton,Florida,34209,United States
Novartis Investigative Site
Recruiting
Suwanee,Georgia,30024,United States
Novartis Investigative Site
Recruiting
Milwaukee,Wisconsin,53226,United States
Novartis Investigative Site
Recruiting
Pensacola,Florida,32514,United States
Novartis Investigative Site
Recruiting
Maitland,Florida,32751,United States
Novartis Investigative Site
Recruiting
Knoxville,Tennessee,37922,United States
Novartis Investigative Site
Recruiting
Hanford,California,93230,United States
Novartis Investigative Site
Recruiting
Kansas City,Kansas,66160,United States
Novartis Investigative Site
Recruiting
El Paso,Texas,79935,United States
Novartis Investigative Site
Recruiting
Indian Land,South Carolina,29707,United States
Novartis Investigative Site
Recruiting
Greer,South Carolina,29650,United States
Novartis Investigative Site
Recruiting
Crab Orchard,West Virginia,25827,United States
Novartis Investigative Site
Recruiting
Owosso,Michigan,48867,United States
Novartis Investigative Site
Recruiting
Sherman,Texas,75092,United States
Novartis Investigative Site
Recruiting
Winter Park,Florida,32789,United States
Novartis Investigative Site
Recruiting
Kansas City,Missouri,64128,United States
Novartis Investigative Site
Recruiting
San Antonio,Texas,78229,United States
Novartis Investigative Site
Recruiting
Patchogue,New York,11772,United States
Novartis Investigative Site
Recruiting
New Orleans,Louisiana,70121,United States
Novartis Investigative Site
Recruiting
Gainesville,Florida,32610,United States
Novartis Investigative Site
Recruiting
Seattle,Washington,98133,United States
Novartis Investigative Site
Recruiting
Colorado Springs,Colorado,80907,United States
Novartis Investigative Site
Recruiting
Port Orange,Florida,32127,United States
Novartis Investigative Site
Recruiting
Boca Raton,Florida,33487,United States
Novartis Investigative Site
Recruiting
Vero Beach,Florida,32960,United States
Novartis Investigative Site
Recruiting
Merrillville,Indiana,46410,United States
Novartis Investigative Site
Recruiting
Charlotte,North Carolina,28210,United States
Novartis Investigative Site
Recruiting
Dayton,Ohio,45408,United States
Novartis Investigative Site
Recruiting
Aurora,Colorado,80045,United States
Novartis Investigative Site
Recruiting
Hollywood,Florida,33021,United States
Novartis Investigative Site
Recruiting
Columbus,Ohio,43235,United States
Novartis Investigative Site
Recruiting
Frederick,Maryland,21702,United States
Novartis Investigative Site
Recruiting
Denver,Colorado,80210,United States
Novartis Investigative Site
Recruiting
Pembroke Pines,Florida,33024,United States
Worldwide Contacts
If the location of your choosing does not feature any contact detail, please reach out using the information below.